McDonald Partners’s Spectrum Pharmaceuticals Inc SPPI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-20,199
Closed -$19.4K 243
2023
Q2
$19.4K Sell
20,199
-14,054
-41% -$13.9K 0.01% 240
2023
Q1
$25.7K Sell
34,253
-6,217
-15% -$4.54K 0.01% 234
2022
Q4
$14.9K Sell
40,470
-2,100
-5% -$886 0.01% 228
2022
Q3
$18K Hold
42,570
0.01% 218
2022
Q2
$33K Hold
42,570
0.01% 294
2022
Q1
$55K Buy
+42,570
New +$39.2K 0.01% 304
2021
Q4
Sell
-44,870
Closed -$98K 737
2021
Q3
$98K Hold
44,870
0.02% 296
2021
Q2
$168K Buy
44,870
+100
+0.2% +$348 0.04% 298
2021
Q1
$146K Hold
44,770
0.04% 286
2020
Q4
$153K Buy
+44,770
New +$184K 0.04% 270

McDonald Partners's SPPI Position: Q3 2023 in Review

McDonald Partners sold out of Spectrum Pharmaceuticals Inc (SPPI) in Q3 2023, closing a stake of 20,199 shares — an estimated $19.4K sold.

McDonald Partners first reported a position in SPPI in Q4 2020 and held it in 10 quarters. The position peaked at $168K in Q2 2021. 0 funds tracked by Wall St. Rank hold SPPI as of Q3 2023.

  • McDonald Partners reported no remaining Spectrum Pharmaceuticals Inc position as of Q3 2023 after selling out during the quarter.
  • McDonald Partners sold 20,199 Spectrum Pharmaceuticals Inc shares in Q3 2023, an estimated $19.4K.
  • McDonald Partners first reported a position in Spectrum Pharmaceuticals Inc in Q4 2020 and held it in 10 quarters.
  • McDonald Partners's Spectrum Pharmaceuticals Inc position peaked at $168K in Q2 2021.
  • 0 funds tracked by Wall St. Rank held Spectrum Pharmaceuticals Inc as of Q3 2023.

Based on McDonald Partners's 13F filing for Q3 2023, filed 30 Oct 2023.